<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04209062</url>
  </required_header>
  <id_info>
    <org_study_id>112365</org_study_id>
    <nct_id>NCT04209062</nct_id>
  </id_info>
  <brief_title>Validation of a High-Quality Low-Cost Open-Source Electrocardiograph</brief_title>
  <official_title>Validation of a High-Quality Low-Cost Open-Source Electrocardiograph (ECG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The high price of electrocardiograph (ECG) devices - with most hospital-grade devices costing
      thousands of dollars - is one of the barriers to access of this vital technology. There is a
      shortage of ECG devices in underserved areas and the devices available on the market
      currently are not adequate to solve this problem. Our solution is a low-cost high-quality
      open-access ECG device. This study intends to validate the study ECG device in human patients
      by demonstrating equivalence between the study ECG device and a gold standard device.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Equivalence of Electrical Signals between 3D printed ECG device and Gold Standard ECG</measure>
    <time_frame>60 seconds</time_frame>
    <description>Comparing electrical signals from ECG electrodes with tested device and gold standard device by collecting the following data from both devices: rate, QR interval, PR interval, QT interval, and rhythm.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Open Access</condition>
  <condition>Medical Devices</condition>
  <condition>Low Cost</condition>
  <condition>Electrocardiograph</condition>
  <arm_group>
    <arm_group_label>Study device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medical device validation</intervention_name>
    <description>The medical devices will both record electrical signals for comparison</description>
    <arm_group_label>Control device</arm_group_label>
    <arm_group_label>Study device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - All study participants must be able to provide written informed consent prior to study
        procedure. This study has 2 Phases.

        Phase 1:

          -  Healthy

          -  &gt; 18 years of age

        Phase 2:

          -  &gt; 18 years of age

          -  non critical patients presenting to the emergency department (Victoria Hospital and
             University Hospital) with cardiac complaint

        Exclusion Criteria:

          -  &lt; 18 years old

          -  Unable to consent

        Phase 1:

          -  &gt; 70 years of age

          -  Previous history of cardiac disease (e.g., atrial fibrillation, myocardial infarction,
             congestive heart failure)

          -  current status of non-sinus heart rhythm

        Phase 2:

        - Critical patients in the ED where consent would inappropriately delay investigations or
        treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tarek Loubani, MD</last_name>
    <phone>15196858500</phone>
    <phone_ext>54970</phone_ext>
    <email>tarek@tarek.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 13, 2018</study_first_submitted>
  <study_first_submitted_qc>December 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2019</study_first_posted>
  <last_update_submitted>March 31, 2020</last_update_submitted>
  <last_update_submitted_qc>March 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lawson Health Research Institute</investigator_affiliation>
    <investigator_full_name>Tarek Loubani, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Open Access</keyword>
  <keyword>Medical Devices</keyword>
  <keyword>Low Cost</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

